Anulex Technologies, Inc. Announces FDA Clearance for Expanded Indications of fiXate™ Tissue Band
4/4/2012 7:14:01 AM
More...
|
Anulex Technologies, Inc. Resolves FDA Warning Letter
3/21/2012 6:52:52 AM
More...
|
Anulex Technologies, Inc. Announces FDA Clearance of the fiXate™ Tissue Band
9/20/2011 10:05:23 AM
More...
|
Layoffs Occur at Anulex Technologies, Inc. Following FDA’s Warning Letter
4/20/2011 8:10:38 AM
More...
|
Anulex Technologies, Inc. to Raise a Minimum of $20 Million in Series E Financing
6/3/2010 1:42:14 PM
More...
|
Anulex Technologies, Inc. Pulls in $4 million
3/26/2010 9:23:28 AM
More...
|
Anulex Technologies, Inc. Announces the Launch of the Xclose(TM) Plus Tissue Repair System and Achieves 7,300 Patients Treated Milestone
2/18/2010 9:22:19 AM
More...
|
Anulex Technologies, Inc. Completes Patient Enrollment Phase of Post Market Study and Announces the Treatment of over 6,000 Patients with the Xclose(TM) Tissue Repair System
11/10/2009 10:06:07 AM
More...
|
Anulex Technologies, Inc. Raises $10.2 Million in Series D Financing and Appoints New Senior Management
6/15/2009 7:42:15 AM
More...
|
Anulex Technologies, Inc. Raises $10.2 Million
5/14/2009 7:59:57 AM
More...
|
|